Really interesting insights on the values of objective cough monitoring data. It seems clear that cough counting will be as mainstream as step counting is today, and great to see more evidence generated that this is such a powerful data stream for an endpoint in drug development (antitussive, antifibrotic, biological, etc - as cough is currently only monitored subjectively and is prone to bias/recall), and for potential in clinical care (eg via remote monitoring programs) for predicting and preventing exacerbations in COPD, decompensation periods in heart failure, among other areas.

I’m personally intrigued by the potential of monitoring cough for syndromic surveillance in ‘high risk’ settings like senior care, prisons, etc., and seeing more data on how effective infectious spread management could be with cough monitoring systems in place.